Dr. Gabriel Pardo
Claim this profileOklahoma Medical Research Foundation
Studies Multiple Sclerosis
Studies Syndrome
9 reported clinical trials
17 drugs studied
Affiliated Hospitals
Clinical Trials Gabriel Pardo is currently running
Ofatumumab
for Multiple Sclerosis
The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).
Recruiting2 awards Phase 3
MSCopilot® App
for Multiple Sclerosis
This trial is testing MSCopilot® Detect, a smartphone app that helps people with Multiple Sclerosis (MS) monitor their condition from home. The app aims to make it easier to track disease progression and improve patient care. It involves 314 MS patients from several countries who will use the app to complete periodic questionnaires and tests. MSCopilot is a software medical device designed for the self-assessment of people with Multiple Sclerosis (PwMS), validated against traditional tests.
Recruiting1 award N/A
More about Gabriel Pardo
Clinical Trial Related5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Gabriel Pardo has experience with
- Ocrelizumab
- RPC-1063
- Placebo For Ocrelizumab
- Ofatumumab
- Seasonal Quadrivalent Influenza Vaccine
- 23-valent Pneumococcal Polysaccharide Vaccine (23-PPV)
Breakdown of trials Gabriel Pardo has run
Multiple Sclerosis
Radiologically Isolated Syndrome
Neuromyelitis Optica (NMO)
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gabriel Pardo specialize in?
Gabriel Pardo focuses on Multiple Sclerosis and Syndrome. In particular, much of their work with Multiple Sclerosis has involved unknown patients, or patients who are undergoing treatment.
Is Gabriel Pardo currently recruiting for clinical trials?
Yes, Gabriel Pardo is currently recruiting for 6 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Gabriel Pardo has studied deeply?
Yes, Gabriel Pardo has studied treatments such as Ocrelizumab, RPC-1063, Placebo for Ocrelizumab.
What is the best way to schedule an appointment with Gabriel Pardo?
Apply for one of the trials that Gabriel Pardo is conducting.
What is the office address of Gabriel Pardo?
The office of Gabriel Pardo is located at: Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the Oklahoma Medical Research Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.